how novo nordisk built an empire selling diabetes and weight-loss drugs
Published 5 months ago • 3.6K plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
19:20
how ozempic and wegovy accidentally made novo nordisk a $400b company
-
4:54
novo nordisk spent $11 million on ozempic promotion
-
7:17
viking therapeutics could be a new winner in the glp-1 space
-
7:57
novo nordisk ceo talks soaring weight-loss drug demand, q1 earnings
-
8:54
how novo nordisk became europe's most valuable company
-
9:56
the story of glp-1: episode 1 - "a diabetes doctor’s dream"
-
28:26
ozempic - what’s the truth behind the hype? | dw documentary
-
5:20
weight loss drugs and why it could impact the food industry
-
7:12
ozempic is a game-changer. here’s how it works.
-
10:52
wegovy, ozempic or mounjaro? how a new wave of weight loss drugs could transform the diet industry
-
2:31
how weight loss drugs could impact stocks
-
5:29
healthcare: best strategies to invest in pharma stocks
-
2:00
mounjaro patients lose weight faster than those on ozempic: study
-
3:26
novo nordisk stock falls on ozempic investigation into possible cancer link
-
1:12
lawmakers propose pathway to allow medicare to cover weight-loss drugs
-
3:26
time100 most influential companies: novo nordisk
-
1:24
weight loss drugs are 'huge market' for pharmaceuticals: analyst
-
1:48
can glp-1 weight-loss drug manufacturers keep momentum up?
-
4:09
weight loss drug wegovy sales fuel novo nordisk stock performance
-
3:32
eli lilly, novo nordisk to test weight loss drugs for children
-
1:29
novo nordisk study shows wegovy can cut heart attack and stroke risk
-
1:29
weight loss drugs: novo nordisk stock hits record high on new data